Elevated CRP levels have also been inversely associated with favorable outcomes following intravenous thrombolysis (IVT), indicating reduced treatment efficacy and safety in AIS patients with exacerbated inflammatory activity [42]. This evidence concerns the gene CRP and androgen insensitivity syndrome.